Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1168 | 992 | 1161 | 1847 | 1607 | - |
Fund Return | 16.78% | -0.8% | 16.13% | 22.69% | 9.96% | - |
Place in category | 8 | 40 | 9 | 1 | 3 | - |
% in Category | 16 | 84 | 23 | 1 | 7 | - |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
AQR Diversified Arbitrage I | 1.24B | 3.11 | 0.97 | 5.05 | ||
AQR Managed Futures Strategy I | 1.28B | 2.20 | 10.27 | 2.84 | ||
AQR Style Premia Alternative R6 | 642.45M | 16.28 | 24.41 | 5.52 | ||
AQR Style Premia Alternative I | 545.74M | 16.23 | 24.30 | 5.42 | ||
AQR Equity Market Neutral I | 432.89M | 18.28 | 24.07 | 6.06 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Victory CEMP Market Neutral Incomei | 2.54B | 0.27 | 2.97 | 3.29 | ||
BlackRock Global Long/Short Equity | 2.16B | 19.04 | 11.82 | 4.28 | ||
Cognios Market Neutral Large Cap In | 1.18B | 8.39 | 8.77 | 3.50 | ||
Cognios Market Neutral LC Investor | 1.18B | 8.17 | 8.51 | 3.25 | ||
PIMCO RAE Fundamental AdvantagePLUS | 480.2M | -3.66 | 2.72 | -0.86 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Limited Purpose Cash Investment | - | 41.50 | - | - | |
United States Treasury Bills 0% | - | 4.96 | - | - | |
United States Treasury Bills 0% | - | 4.39 | - | - | |
United States Treasury Bills 0% | - | 3.74 | - | - | |
United States Treasury Bills 0% | - | 2.93 | - | - |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Buy | Buy | Buy |
Technical Indicators | Strong Buy | Strong Buy | Strong Buy |
Summary | Strong Buy | Strong Buy | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review